New Jersey A 2020: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced, Referred to Assembly Health Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 2020

Sponsors: Haider, Shama A.

View New Jersey A 2020 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.